DuLac Farmaceutici, an Italian pharmaceutical company known for its recovery-focused dermo-cosmetic products, announced plans to expand its presence in the United States as consumer demand grows through its Amazon platform. The company aims to reach more Americans by broadening availability across retail, e-commerce, wellness, and distribution channels.
DuLac’s U.S. presence is currently anchored by its Amazon storefront, where American consumers can purchase products such as Arnica Gel 98%, Dinaven, and Diosmin lines. These products target recovery, vascular wellness, and microcirculation support, catering to active lifestyles and long-distance travel needs. The company reports strong consumer engagement, particularly with its high-concentration Arnica Gel 98%, which appeals to athletes and wellness-conscious individuals.
“DuLac was built on the belief that consumers deserve products that combine traditional botanical knowledge with rigorous pharmaceutical standards,” said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. “As more U.S. consumers discover our products through Amazon, we see a clear opportunity to expand access across additional channels and introduce more Americans to Italian pharmacy innovation.”
The expansion comes as American consumers increasingly prioritize year-round wellness, with seasonal shifts driving demand for muscle recovery and venous support. DuLac’s products, developed over 30 years of European pharmaceutical expertise, address these needs by merging traditional botanicals with modern science. The company’s proprietary Arnica Montana Arricchita™ project uses indoor vertical farming to ensure botanical integrity, while its micronized Diosmin MPFF technology doubles intestinal absorption for targeted vascular support.
Technological advancements, including solvent-free Supercritical CO₂ Extraction and GMP/ISO-certified manufacturing, define DuLac’s approach. These innovations are central to the company’s strategy as it seeks to establish a pharmacy-grade presence in the U.S. wellness market. The company views the Dinaven and Diosmin lines as key growth categories for vascular wellness and microcirculation support, areas where it sees significant potential for American consumers.
DuLac’s expansion plan focuses on increasing consumer awareness and building partnerships across retail, wholesale, and wellness channels. By leveraging its Amazon success as a foundation, the company aims to introduce its Italian pharmacy heritage to a broader U.S. audience. With a portfolio that combines botanical innovation and advanced extraction technologies, DuLac hopes to provide reliable, scientifically backed wellness solutions for everyday well-being.
